Gastrointestinal Prophylaxis in High-Risk Patients

Patient Selection

• Mechanical ventilation for more than 48 hours is a strong predictor for gastrointestinal bleeding, according to the American Association for the Study of Liver Diseases, and such patients should receive GI prophylaxis 1, 2
• Coagulopathy is one of the strongest clinical predictors of GI bleeding, with an odds ratio of 4.3, and patients with this condition should receive prophylaxis, as recommended by the American Association for the Study of Liver Diseases 1, 2
• Acute liver failure requiring ICU admission is a high-risk criterion for GI bleeding, and these patients should receive prophylaxis, as stated by the American Association for the Study of Liver Diseases 1
• Severe liver disease, such as a MELD score of 35 or higher, is a high-risk criterion for GI bleeding, and patients with this condition should receive prophylaxis, according to the American Association for the Study of Liver Diseases 2
• Patients with a history of GI bleeding or peptic ulcer disease are at increased risk and should receive prophylaxis, as recommended by the American College of Gastroenterology 2
• Major surgery, such as vascular or abdominal surgery, is a moderate-risk criterion for GI bleeding, and patients who undergo such procedures should be considered for prophylaxis, as stated by the American College of Surgeons 2
• Cancer patients with neutropenia do not require routine prophylaxis for infectious diarrhea, but may require prophylaxis for stress ulcers if other high-risk criteria are met, according to the European Society for Medical Oncology 3

Prophylactic Agents

• Proton pump inhibitors (PPIs) are preferred over H2-receptor antagonists (H2RAs) for stress ulcer prophylaxis in high-risk patients, as recommended by the American College of Gastroenterology 2
• Intravenous pantoprazole 40 mg daily is the preferred agent for critically ill patients who are unable to take oral medications, particularly those with severe liver disease, as stated by the American Association for the Study of Liver Diseases 2
• H2-receptor antagonists, such as ranitidine, are effective but may be associated with drug interactions and encephalopathy in neurocritical patients, and should be used with caution, as recommended by the Neurocritical Care Society 1

Timing and Duration

• Prophylaxis should be initiated immediately upon ICU admission for high-risk patients, as recommended by the Society of Critical Care Medicine 2
• Prophylaxis should be continued as long as risk factors persist and critical illness continues, and should be discontinued when sepsis resolves and the patient tolerates enteral nutrition, as stated by the Society of Critical Care Medicine 2
• The need for prophylaxis should be reevaluated daily based on risk factor resolution, as recommended by the American College of Gastroenterology 2

Monitoring

• Patients should be monitored for signs of GI bleeding, such as melena, hematemesis, and hemoglobin drop, from admission, as recommended by the American College of Gastroenterology 2
• Surveillance should continue throughout the ICU stay in high-risk patients, as stated by the Society of Critical Care Medicine 2